CaliPharms
(OTCEM:KGET)
$~0
0[0.00%]
At close: Feb 26

GET A REPORT ON KGET SENT RIGHT TO YOUR INBOX

12.5%
Overview Rating
Very unpromising asset
Technicals Analysis
33
0100
Financials Analysis
0
0100

CaliPharms Stock (OTC:KGET), Quotes and News Summary

CaliPharms Stock (OTC: KGET) stock price, news, charts, stock research, profile.
Open-
Close-
Volume / Avg.0 / 1.093M
Day Range- - -
52 Wk Range0.000 - 0.000
Market Cap$4.012K
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest
%
Days to Cover-
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell
About CaliPharms Inc
Sector
Industrials
Industry
Machinery
CaliPharms Inc is a United States-based company focused on the medical marijuana-cannabis industry. ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
KGET

FAQ

Q

How do I buy CaliPharms (KGET) stock?

A

You can purchase shares of CaliPharms (OTCEM: KGET) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CaliPharms's (KGET) competitors?

A

There are no as such competitors for CaliPharms.

Q

What is the target price for CaliPharms (KGET) stock?

A

There is no analysis for CaliPharms

Q

Current Stock Price for CaliPharms (KGET)?

A

The stock price for CaliPharms (OTCEM: KGET) is $0.000001 last updated February 26, 2024 at 11:34 AM EST.

Q

Does CaliPharms (KGET) pay a dividend?

A

There are no upcoming dividends for CaliPharms.

Q

When is CaliPharms (OTCEM:KGET) reporting earnings?

A

CaliPharms does not have any upcoming earnings scheduled.

Q

Is CaliPharms (KGET) going to split?

A

There is no upcoming split for CaliPharms.

Q

What sector and industry does CaliPharms (KGET) operate in?

A

CaliPharms is in the Industrials sector and Machinery industry. They are listed on the OTCEM.

People Also Watch